What Pharmacies Need to Know About MFP, the IRA, and M&A Trends

Independent pharmacies are navigating a period of ongoing change, from evolving federal policy to continued consolidation across the market. At K&B Pharmacy Associates, we focus on helping members understand what’s happening, what it may mean for their operations, and where to stay attentive.

K&B Pharmacy Associates attended live Beacon support sessions that delved into Market Fair Price (MFP) under the Inflation Reduction Act (IRA) and ongoing merger and acquisition activity across the pharmacy landscape. Here are our takeaways.

Understanding MFP and the Inflation Reduction Act

The Inflation Reduction Act is significantly influencing how certain drugs are priced within Medicare, especially with the introduction of MFP for selected medications.

Independent pharmacies should monitor this situation closely. While the MFP aims to regulate drug pricing at the federal level, it can also affect several key areas, including:

·         Predictability of reimbursements

·         Pharmacy acquisition costs

·         Margin pressure on specific medications

·         Increased operational complexity in billing and compliance

It is essential to understand that the full impact of these changes on pharmacies is still unfolding. As the implementation progresses, pharmacies may notice alterations in how certain claims are reimbursed or processed. For more information, visit https://mfp.beaconchannelmanagement.com/ or call 1-878-788-8980.

Why This Matters to Independent Pharmacies

Policy changes like MFP don’t happen in isolation. They interact with existing dynamics such as PBM practices, reimbursement variability, and supply chain pressures.

For pharmacy owners, this can create:

·         Increased uncertainty around profit margins

·         A heightened need to focus on drug-level profitability

·         Greater emphasis on purchasing strategies and vendor alignment

This is where having access to aggregated purchasing support and practical business insights becomes increasingly valuable. 

Starting in 2027 and 2028, an additional 15 drugs will be selected each year, increasing to up to 20 drugs annually beginning in 2029. This will significantly increase the number of therapies facing pricing pressure over time.

Merger and Acquisition Activity: What We're Seeing in the Market

Alongside policy changes, M&A continues to shape the pharmacy landscape.

We are seeing ongoing consolidation across:

·         Retail pharmacy chains

·         PBM and payer-aligned entities

·         Regional pharmacy groups

This activity can influence independent pharmacies in several ways:

·         Network participation dynamics may shift

·         Local competition may change

·         Negotiating leverage can be affected

·         Patient access patterns may evolve

M&A is not just a market activity; it can also be a strategic option for independent owners.

Some pharmacies are exploring:

·         Growth through acquisition

·         Exit planning or succession strategies

·         Partnerships that strengthen long-term viability

K&B Pharmacy Associates supports members by providing buy-sell advisory and practical guidance, helping owners evaluate options based on their specific goals and market conditions.

Here's What You Can Control

Between policy changes like the IRA and broader market consolidation, it’s easy for pharmacy owners to feel like decisions are being made far outside their control.

But there are still areas where independent pharmacies can stay proactive:

·         Evaluating purchasing strategies

·         Reviewing vendor relationships

·         Monitoring reimbursement trends at the drug level

·         Planning for growth, transition, or exit

K&B Pharmacy Associates' focus remains consistent: helping independent pharmacies strengthen purchasing and business performance with support built for real pharmacy operations.

The landscape is shifting, but not all at once, and not without opportunities to adapt. MFP, the IRA, and continued M&A activity are all developments worth watching. The pharmacies that stay informed and operationally focused will be in a stronger position to respond as these changes continue to unfold.

K&B Pharmacy Associates will continue to share updates, practical context, and member-focused insights. If you would like to schedule a one-on-one consultation with us about group purchasing, buy-sell advisory, or strategic initiatives, fill out our contact form, and we will be in touch shortly!

Sources:

1. https://mfp.beaconchannelmanagement.com/